Prospective evaluation of an algorithm for the phenotypic screening of carbapenemase-producing Enterobacteriaceae

被引:34
|
作者
Dortet, Laurent [1 ,2 ,3 ]
Cuzon, Gaelle [1 ,2 ,3 ]
Plesiat, Patrick [4 ]
Naas, Thierry [1 ,2 ,3 ]
机构
[1] Bicetre Hosp, Assistance Publ Hop Paris, Bacteriol Hyg Unit, Le Kremlin Bicetre, France
[2] French Natl Reference Ctr Antibiot Resistance Car, Le Kremlin Bicetre, France
[3] Univ Paris Sud, Fac Med, LabEx LERMIT, Res Unit Struct Dynam Funct & Express Broad Spect, F-94275 Le Kremlin Bicetre, France
[4] Univ Hosp, French Natl Reference Ctr Antibiot Resistance, Besancon, France
关键词
RAPID DETECTION; KLEBSIELLA-PNEUMONIAE; RESISTANCE; DIFFUSION; TESTS;
D O I
10.1093/jac/dkv308
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The objective of this study was to assess the performance of an algorithm based on the disc diffusion method for the screening of carbapenemase-producing Enterobacteriaceae (CPE) referred to the French National Reference Centre for Antibiotic Resistance. Methods: From April to June 2014, all isolates of Enterobacteriaceae referred to the French National Reference Centre for Antibiotic Resistance were included. The inhibition zone diameters of imipenem, ticarcillin/clavulanate and temocillin using EUCAST disc diffusion methodology were recorded. All isolates were subjected to the algorithm proposed by the Antibiogram Committee of the French Society of Microbiology (CA-SFM) for the screening of carbapenemase producers. Phenotypic, biochemical and molecular detection of carbapenemases was performed for all isolates. Results: A total of 621 consecutive enterobacterial isolates with decreased susceptibility to carbapenems were tested. They included 213 CPE [OXA-48-like (n=183), NDM (n=22), VIM (n=3), KPC (n=3) and OXA-48-like+NDM (n=2)] and 408 non-carbapenemase producers. The CA-SFM algorithm combining cut-off values of 15 mm, 15 mm and 22 mm for ticarcillin/clavulanate, temocillin and imipenem, respectively, perfectly detected 204 isolates (32.8%) as non-carbapenemase producers, leading to a negative predictive value of 100% for this algorithm. Conclusions: Implementation of the CA-SFM algorithm in clinical microbiology laboratories may avoid additional testing for CPE in one-third of the enterobacterial isolates with decreased susceptibility to carbapenems.
引用
收藏
页码:135 / 140
页数:6
相关论文
共 50 条
  • [31] Laboratory detection of carbapenemase-producing Enterobacteriaceae
    Cercenado, Emilia
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2015, 28 : 8 - 11
  • [32] Carbapenemase-Producing Enterobacteriaceae in Spain in 2012
    Oteo, Jesus
    Saez, David
    Bautista, Veronica
    Fernandez-Romero, Sara
    Manuel Hernandez-Molina, Juan
    Perez-Vazquez, Maria
    Aracil, Belen
    Campos, Jose
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (12) : 6344 - 6347
  • [33] Therapeutic options for carbapenemase-producing Enterobacteriaceae
    Salgado, Patricia
    Gilsanz, Fernando
    Maseda, Emilio
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2015, 28 : 12 - 15
  • [34] Global Spread of Carbapenemase-producing Enterobacteriaceae
    Nordmann, Patrice
    Naas, Thierry
    Poirel, Laurent
    EMERGING INFECTIOUS DISEASES, 2011, 17 (10) : 1791 - 1798
  • [35] Emergence of carbapenemase-producing Enterobacteriaceae in Malawi
    Lewis, Joseph M.
    Lester, Rebecca
    Mphasa, Madalitso
    Banda, Rachel
    Edwards, Thomas
    Thomson, Nicholas R.
    Feasey, Nicholas
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 20 : 225 - 227
  • [36] Rapid Detection of Carbapenemase-producing Enterobacteriaceae
    Nordmann, Patrice
    Poirel, Laurent
    Dortet, Laurent
    EMERGING INFECTIOUS DISEASES, 2012, 18 (09) : 1503 - 1507
  • [37] Carbapenemase-producing Enterobacteriaceae in transplant patients
    Giannella, Maddalena
    Bartoletti, Michele
    Conti, Michela
    Righi, Elda
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 : I27 - I39
  • [38] Strategies for identification of carbapenemase-producing Enterobacteriaceae
    Nordmann, Patrice
    Poirel, Laurent
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (03) : 487 - 489
  • [39] Patient experience of hospital screening for carbapenemase-producing Enterobacteriaceae: A qualitative study
    King, Caroline
    Grandison, Tracyanne
    Cawthorne, Julie
    Currie, Kay
    JOURNAL OF CLINICAL NURSING, 2019, 28 (21-22) : 3890 - 3900
  • [40] Screening suspected cases for carbapenemase-producing Enterobacteriaceae, inclusion criteria and demand
    Venanzio, Vella
    Gharbi, Myriam
    Moore, Luke S. P.
    Robotham, Julie
    Davies, Frances
    Brannigan, Eimear
    Galletly, Tracey
    Holmes, Alison H.
    JOURNAL OF INFECTION, 2015, 71 (04) : 493 - 495